Revenue
13.5 million Unit1
2012 Q2 · Unit1
Exact inputs and evidence
- Revenue: 13472000 Unit1 Source
Fundies. English
ALLOS THERAPEUTICS INC
EDGAR70 filing records in this dataset, filed from 2000-05-15 to 2012-08-17. Reported financial figures are available; chart coverage varies by period.
Latest quarter
Operating margin
-59.32%
2012 Q2 · %
Operating cash flow
-5.89 million Unit1
2012 Q2 · Unit1
- Cash and cash equivalents
- 87.6 million Unit1 Source
Exact value
87556000 Unit1
- Long-term debt including current maturities
- Not available
- Shares outstanding
- 107 million Unit15 Source
Exact value
106974662 Unit15
Trailing twelve months
The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.
Revenue
55.6 million Unit1
2011-07-01 – 2012-06-30
Exact inputs and evidence
Capital expenditure
156 thousand USD
2010-10-01 – 2011-09-30
Exact inputs and evidence
- Capital expenditure: 1016000 USD · 2010-01-01 – 2010-12-31 Source
- Capital expenditure: 937000 USD · 2010-01-01 – 2010-09-30 Source
- Capital expenditure: 39000 USD · 2011-01-01 – 2011-03-31 Source
- Capital expenditure: 65000 USD · 2011-01-01 – 2011-06-30 Source
- Capital expenditure: 39000 USD · 2011-01-01 – 2011-03-31 Source
- Capital expenditure: 77000 USD · 2011-01-01 – 2011-09-30 Source
- Capital expenditure: 65000 USD · 2011-01-01 – 2011-06-30 Source
Includes later revisions to earlier periods. Annual charts exclude incomplete years.
Latest filing recorded: 2012-08-17.
Financial data available through: 2011-12-31.
Coverage by financial measure
- Revenue: 3 of 11 periods available· newest 2011-12-31
- Operating income: 3 of 11 periods available· newest 2011-12-31
- Net income: 3 of 11 periods available· newest 2011-12-31
- Operating cash flow: 3 of 11 periods available· newest 2011-12-31
- Capital expenditure: 8 of 11 periods available· newest 2010-12-31
- Total assets: 2 of 11 periods available· newest 2011-12-31
- liabilities: No compatible figures in this window
- Current assets: 2 of 11 periods available· newest 2011-12-31
- Current liabilities: 2 of 11 periods available· newest 2011-12-31
- Cash and cash equivalents: 3 of 11 periods available· newest 2011-12-31
- long term debt: No compatible figures in this window
- Shares outstanding: Multiple units; comparison withheld· newest 2011-12-31
Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.
What changed year over year
Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.
Revenue
+115.9%Prior period
Unit1 35.23 million
–
Current period
Unit1 76.05 million
–
Exact inputs and evidence
76049000 − 35227000 = 40822000 Unit1
35227000 Unit1 · 2010-01-01 – 2010-12-31
Inspect prior input Prior source76049000 Unit1 · 2011-01-01 – 2011-12-31
Inspect current input Current sourceShare or cite
The citation records this snapshot. The page link may show a newer release later.
Net income
+Unit1 46.89 millionPrior period
−Unit1 77.42 million
–
Current period
−Unit1 30.53 million
–
Exact inputs and evidence
-30527000 − -77417000 = 46890000 Unit1
-77417000 Unit1 · 2010-01-01 – 2010-12-31
Inspect prior input Prior source-30527000 Unit1 · 2011-01-01 – 2011-12-31
Inspect current input Current sourceShare or cite
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
+Unit1 62.9 millionPrior period
−Unit1 63.66 million
–
Current period
−Unit1 752,000
–
Exact inputs and evidence
-752000 − -63656000 = 62904000 Unit1
-63656000 Unit1 · 2010-01-01 – 2010-12-31
Inspect prior input Prior source-752000 Unit1 · 2011-01-01 – 2011-12-31
Inspect current input Current sourceShare or cite
The citation records this snapshot. The page link may show a newer release later.
Comparable inputs unavailable for: Capital expenditure.
Where revenue goes
How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.
2011 2011-01-01 – 2011-12-31
- Revenue Unit1 76.05 million 100% of revenue
- Operating costs Derived Unit1 106.67 million 140% of revenue
- Operating income −Unit1 30.62 million −40% of revenue
- Tax, interest and other Derived −Unit1 92,000 −0.1% of revenue
- Net income −Unit1 30.53 million −40% of revenue
Cash
- Operating cash flow −Unit1 752,000 −1% of revenue
- Capital expenditure Unavailable An input is unavailable.
- Free cash flow Derived Unavailable An input is unavailable.
Share of revenue by period
- Net income
- Tax, interest and other
- Operating costs
- 2009 Operating loss: operating costs were 2,164% of revenue.
- 2010 Operating loss: operating costs were 324% of revenue.
- 2011 Operating loss: operating costs were 140% of revenue.
Values and sources
| Period | Revenue | Operating costs | Operating income | Tax, interest and other | Net income | Free cash flow | Source |
|---|---|---|---|---|---|---|---|
| 2009 2009-01-01 – 2009-12-31 | 3585000 | 77595000 Derived | -74010000 | -457000 Derived | -73553000 | Unavailable | Source
|
| 2010 2010-01-01 – 2010-12-31 | 35227000 | 114242000 Derived | -79015000 | -1598000 Derived | -77417000 | Unavailable | Source
|
| 2011 2011-01-01 – 2011-12-31 | 76049000 | 106668000 Derived | -30619000 | -92000 Derived | -30527000 | Unavailable | Source
|
Amounts are exact, in Unit1.
Growth
Sales over time and how quickly they are changing.
Revenue
Revenue reported for each complete financial period.
Unit1 76M 2011
Values and sources
| Period | Series | Value(Unit1) | Source evidence |
|---|---|---|---|
| 2009 | Revenue | 3585000 |
|
| 2010 | Revenue | 35227000 |
|
| 2011 | Revenue | 76049000 |
|
Revenue growth
Change in revenue from the same financial period one year earlier.
115.9% 2011
Values and sources
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2009 | Year over year | No prior comparable period |
|
| 2010 | Year over year | 882.6% |
|
| 2011 | Year over year | 115.9% |
|
Profit and cash
How much revenue becomes profit, and how much cash operations generate.
Profit margins
Operating income, net income and free cash flow as a share of revenue.
Operating margin -40.3% 2011
Net margin -40.1% 2011
- Operating margin
- Net margin
- Free cash flow margin
Values and sources
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2009 | Operating margin | -2,064.4% |
|
| 2010 | Operating margin | -224.3% |
|
| 2011 | Operating margin | -40.3% |
|
| 2009 | Net margin | -2,051.7% |
|
| 2010 | Net margin | -219.8% |
|
| 2011 | Net margin | -40.1% |
|
| 2009 | Free cash flow margin | Not reported |
|
| 2010 | Free cash flow margin | Not reported |
|
| 2011 | Free cash flow margin | Not reported |
|
Operating cash flow
Cash generated by the company’s normal business operations.
Unit1 -752K 2011
Values and sources
| Period | Series | Value(Unit1) | Source evidence |
|---|---|---|---|
| 2009 | Operating cash flow | -62199000 |
|
| 2010 | Operating cash flow | -63656000 |
|
| 2011 | Operating cash flow | -752000 |
|
Free cash flow
Operating cash flow minus capital expenditure for the same period and unit.
Not enough comparable data to show this history.
Values and sources
| Period | Series | Value(Unit1) | Source evidence |
|---|---|---|---|
| 2009 | Free cash flow | Unavailable |
|
| 2010 | Free cash flow | Unavailable |
|
| 2011 | Free cash flow | Unavailable |
|
Balance sheet
Liabilities and short-term ability to meet obligations at each period end.
Liabilities to assets
Total liabilities as a share of total assets.
Not enough comparable data to show this history.
Values and sources
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2009-12-31 | Liabilities / assets | Not reported | No source recorded |
| 2010-12-31 | Liabilities / assets | Not reported |
|
| 2011-12-31 | Liabilities / assets | Not reported |
|
Current assets to current liabilities
Current assets divided by current liabilities.
5.53× 2011
Values and sources
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2009-12-31 | Current assets / current liabilities | Not reported | No source recorded |
| 2010 | Current assets / current liabilities | 5.02× |
|
| 2011 | Current assets / current liabilities | 5.53× |
|
Cash generation
Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.
| Period | Net income | Operating cash flow | Capital expenditure | Free cash flow |
|---|---|---|---|---|
| 2009 2009-01-01 – 2009-12-31 | −Unit1 73.55 million Exact valueExact value: -73553000 Unit1 Share or citeThe citation records this snapshot. The page link may show a newer release later. | −Unit1 62.2 million Exact valueExact value: -62199000 Unit1 Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2010 2010-01-01 – 2010-12-31 | −Unit1 77.42 million Exact valueExact value: -77417000 Unit1 Share or citeThe citation records this snapshot. The page link may show a newer release later. | −Unit1 63.66 million Exact valueExact value: -63656000 Unit1 Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2011 2011-01-01 – 2011-12-31 | −Unit1 30.53 million Exact valueExact value: -30527000 Unit1 Share or citeThe citation records this snapshot. The page link may show a newer release later. | −Unit1 752,000 Exact valueExact value: -752000 Unit1 Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.
Dataset coverage and company identifiers
Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.
70 filings · 418 latest values · 418 originally reported values
Dataset published . Source filing dates and reporting periods are shown separately.
Identifiers: 0001097264, 1097264, edgar:1097264
Also known as ALLOS THERAPEUTICS, ALLOS THERAPEUTICS INC